Clinical Trials · NCT01674621

Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis

Name: Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Abaloparatide

Phase: Phase 2
Recruitment status: Completed
Sponsor: Radius Health, Inc.
Enrollment: 250
Start date: Sep 2012
Locations: 9 sites, 4 countries
Primary endpoint: Percent Change From Baseline in Bone Mineral Density (BMD) of Lumbar Spine at 6 Months

View Abaloparatide compound reference